Utama › Kanser Endometrium
Kajian klinikal Kanser Endometrium sedang mengambil peserta di AS
168 kajian untuk Kanser Endometrium sedang mengambil peserta di lokasi seluruh Amerika Syarikat.
Bandar dengan paling banyak kajian
- Houston, TX68 kajian
- New York City, NY52 kajian
- Boston, MA50 kajian
- Arlington, VA39 kajian
- Nashville, TN38 kajian
- Los Angeles, CA34 kajian
- St. Louis, MO29 kajian
- Philadelphia, PA28 kajian
- San Antonio, TX27 kajian
- Queens, NY25 kajian
- Columbus, OH25 kajian
- Chicago, IL25 kajian
- Oklahoma City, OK25 kajian
- Dallas, TX24 kajian
- Portland, OR24 kajian
- Pittsburgh, PA23 kajian
- Detroit, MI21 kajian
- Cleveland, OH20 kajian
- Rochester, MN20 kajian
- Edison, NJ19 kajian
- Washington, DC18 kajian
- Minneapolis, MN18 kajian
- Grand Rapids, MI18 kajian
- Orlando, FL17 kajian
- Atlanta, GA17 kajian
- Seattle, WA17 kajian
- Baldwin Park, CA17 kajian
- Durham, NC16 kajian
- Miami, FL16 kajian
- Birmingham, AL16 kajian
- San Diego, CA16 kajian
- Austin, TX15 kajian
- Denver, CO15 kajian
- Tampa, FL15 kajian
- Sarasota, FL15 kajian
- New Haven, CT14 kajian
- Providence, RI14 kajian
- Salt Lake City, UT14 kajian
- Indianapolis, IN14 kajian
- Aurora, CO14 kajian
Mengikut negeri
- Alabama19 kajian
- Alaska4 kajian
- Arizona22 kajian
- Arkansas12 kajian
- California73 kajian
- Colorado30 kajian
- Connecticut20 kajian
- Delaware4 kajian
- Florida65 kajian
- Georgia24 kajian
- Hawaii3 kajian
- Idaho4 kajian
- Illinois38 kajian
- Indiana19 kajian
- Iowa10 kajian
- Kansas5 kajian
- Kentucky10 kajian
- Louisiana15 kajian
- Maine7 kajian
- Maryland22 kajian
- Massachusetts53 kajian
- Michigan43 kajian
- Minnesota39 kajian
- Mississippi5 kajian
- Missouri31 kajian
- Montana5 kajian
- Nebraska10 kajian
- Nevada8 kajian
- New Jersey32 kajian
- New Mexico13 kajian
- New York69 kajian
- North Carolina31 kajian
- North Dakota6 kajian
- Ohio50 kajian
- Oklahoma28 kajian
- Oregon27 kajian
- Pennsylvania42 kajian
- Rhode Island14 kajian
- South Carolina9 kajian
- South Dakota11 kajian
- Tennessee41 kajian
- Texas91 kajian
- Utah25 kajian
- Virginia51 kajian
- Washington20 kajian
- West Virginia4 kajian
- Wilayah Columbia10 kajian
- Wisconsin24 kajian
Kajian yang dikemas kini baru-baru ini
Teks kajian rasmi (Bahasa Inggeris)
Tirzepatide in Obesity-Driven Endometrial Cancer
Mengambil pesertaFasa awal 1
Umur 18 ke atas · Wanita · Dikemas kini 2 Okt 2026 · NCT07065552Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Mengambil pesertaFasa 2
Semua umur · Semua jantina · Dikemas kini 2 Okt 2026 · NCT05564377Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer
Mengambil pesertaFasa 1
Umur 18 ke atas · Wanita · Dikemas kini 2 Okt 2026 · NCT05950464The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
Mengambil peserta
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07059884A Study to Investigate Mocertatug Rezetecan Compared With Chemotherapy in Participants With Endometrial Cancer After Platinum-based Chemotherapy and Immunotherapy (BEHOLD-Endometrial01)
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 2 Okt 2026 · NCT07286331A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06270706Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer
Mengambil pesertaFasa 3
Umur 18 ke atas · Wanita · Dikemas kini 2 Okt 2026 · NCT07198074A Phase 1 Study of the Safety and Tolerability of CTX-10726
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07419841Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Mengambil pesertaFasa 2
Umur 18 hingga 72 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT01174121A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06760819A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 19 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06586957A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06172478177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT07189871The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07285044A Phase 1, First-in-Human (FIH), Open-Label, Dose-Escalation and Dose Expansion Study of the Peptide Drug Conjugate (PDC), TS-104, as a Monotherapy in Subjects With Select Advanced Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT07814248Leveraging Methylated DNA Markers (MDMs) in the Detection of Endometrial Cancer, Ovarian Cancer, and Cervical Cancer
Mengambil pesertaKajian pemerhatian
Umur 18 ke atas · Wanita · Dikemas kini 29 Sep 2026 · NCT05051722Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 28 Sep 2026 · NCT05112601Study of AVZO-021 in Patients With Advanced Solid Tumors
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT05867251DESTINY-PANTUMOUR04
Mengambil pesertaKajian pemerhatian
Umur 18 hingga 130 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT07124000Phase 1 Study to Investigate TCRTs KRAS Mutation in Unresectable, Advanced, and/or Metastatic Solid Tumors
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06218914ctDNA Testing to Inform Standard-of-Care Treatment Decisions in People With Endometrial Cancer
Mengambil peserta
Umur 18 ke atas · Wanita · Dikemas kini 25 Sep 2026 · NCT07270666Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Wanita · Dikemas kini 25 Sep 2026 · NCT03564340Pembrolizumab and Lenvatinib in Mismatch Repair Proficient Recurrent Endometrial Cancer After Progression on or Following First-Line Immunotherapy Maintenance
Mengambil pesertaFasa 2
Umur 18 ke atas · Wanita · Dikemas kini 24 Sep 2026 · NCT07594015A Study to Find Out How Safe REGN5668 is and How Well it Works In Adult Women When Given With Either Cemiplimab, or Cemiplimab + Fianlimab, or Ubamatamab
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Wanita · Dikemas kini 24 Sep 2026 · NCT04590326Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.